OKYO Pharma Ltd. Insider Trading
OKYO
Insiders bought 136K on the open market and sold nothing.
Get an email when OKYO's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27 | Rajkumar V. Patil Chief Scientific Officer | Bought | 3,363 | $1.49 | 5K | 20% | Form 4 |
| Jul 22 | Robert John Dempsey Chief Executive Officer | Bought | 15,000 | $1.54 | 23K | New | Form 4 |
| Jul 21 | John P Brancaccio Director | Bought | 5,000 | $1.48 | 7K | 17% | Form 4 |
| Jul 21 | Gary S Jacob Chief Development Officer | Bought | 3,500 | $1.40 | 5K | 3.2% | Form 4 |
| Jul 21 | Flavio Mantelli Chief Medical Officer | Bought | 20,000 | $1.40 | 28K | New | Form 4 |
| Jul 21 | Gabriele M Cerrone Director | Bought | 22,500 | $1.45 | 33K | 0.2% | Form 4 |
| Jul 20 | Gabriele M Cerrone Director | Bought | 25,000 | $1.40 | 35K | 0.2% | Form 4 |
- Jul 27Rajkumar V. PatilChief Scientific Officer · bought 3,363 at $1.495K20% of stake
- Jul 22Robert John DempseyChief Executive Officer · bought 15,000 at $1.5423KNew position
- Jul 21John P BrancaccioDirector · bought 5,000 at $1.487K17% of stake
- Jul 21Gary S JacobChief Development Officer · bought 3,500 at $1.405K3.2% of stake
- Jul 21Flavio MantelliChief Medical Officer · bought 20,000 at $1.4028KNew position
- Jul 21Gabriele M CerroneDirector · bought 22,500 at $1.4533K0.2% of stake
- Jul 20Gabriele M CerroneDirector · bought 25,000 at $1.4035K0.2% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with OKYO
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing OKYO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.